{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:00:44Z","timestamp":1789898444492,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.vhri.2026.101667","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:34:05Z","timestamp":1782128045000},"page":"101667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Health Utility and Validity of the EQ-5D-5L in Thai Patients With Pemphigus and Bullous Pemphigoid"],"prefix":"10.1016","volume":"58","author":[{"given":"Arisara","family":"Luangsukrerk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinnaree","family":"Kattipathanapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phantipa","family":"Sakthong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vhri.2026.101667_bib1","series-title":"Dermatology 2020","first-page":"181","article-title":"Vesiculobullous diseases","author":"Aunhachoke","year":"2012"},{"issue":"6","key":"10.1016\/j.vhri.2026.101667_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.33192\/Smj.2021.47","article-title":"Prevalence and pattern of diseases of the skin and subcutaneous tissue in A primary care area in Thailand","volume":"73","author":"Chaiyamahapurk","year":"2021","journal-title":"Siriraj Med J"},{"issue":"5","key":"10.1016\/j.vhri.2026.101667_bib3","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/bjd.15280","article-title":"The burden of common skin diseases assessed with the EQ5D\u2122: a European multicentre study in 13 countries","volume":"176","author":"Balieva","year":"2017","journal-title":"Br J Dermatol"},{"issue":"15","key":"10.1016\/j.vhri.2026.101667_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2147\/CCID.S324331","article-title":"Patient quality of life improvement in bullous disease: a review of primary literature and considerations for the clinician","volume":"Volume","author":"Padniewski","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"9","key":"10.1016\/j.vhri.2026.101667_bib5","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/jdv.16752","article-title":"Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"34","author":"Joly","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.vhri.2026.101667_bib6","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/jdv.18220","article-title":"Updated S2K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"36","author":"Borradori","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.vhri.2026.101667_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13671-016-0140-y","article-title":"Approach and management of autoimmune blistering diseases","volume":"5","author":"Zhao","year":"2016","journal-title":"Curr Dermatol Rep"},{"issue":"5","key":"10.1016\/j.vhri.2026.101667_bib8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5021\/ad.2015.27.5.492","article-title":"Quality of life assessment in Korean patients with pemphigus","volume":"27","author":"Sung","year":"2015","journal-title":"Ann Dermatol"},{"issue":"1","key":"10.1016\/j.vhri.2026.101667_bib9","article-title":"Assessing quality of life in patients with autoimmune bullous diseases using the Persian version of Treatment of Autoimmune Bullous Disease Quality of Life questionnaire finds similar effects in women as men","volume":"8","author":"Behkar","year":"2022","journal-title":"Int J Womens Dermatol"},{"issue":"1","key":"10.1016\/j.vhri.2026.101667_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.33192\/smj.v76i1.248614","article-title":"Clinical characteristics and survival of pemphigoid and pemphigus patients in a Thai population","volume":"76","author":"Insan","year":"2024","journal-title":"Siriraj Med J"},{"key":"10.1016\/j.vhri.2026.101667_bib11","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2147\/DDDT.S306046","article-title":"Rituximab therapy for treatment of pemphigus in Southeast Asians","volume":"15","author":"Kanokrungsee","year":"2021","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.vhri.2026.101667_bib12","series-title":"Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation","author":"Patrick","year":"1993"},{"issue":"1","key":"10.1016\/j.vhri.2026.101667_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldq033","article-title":"Health outcomes in economic evaluation: the QALY and utilities","volume":"96","author":"Whitehead","year":"2010","journal-title":"Br Med Bull"},{"issue":"2","key":"10.1016\/j.vhri.2026.101667_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40258-017-0310-5","article-title":"EQ-5D and the EuroQol Group: past, present and future","volume":"15","author":"Devlin","year":"2017","journal-title":"Appl Health Econ Health Policy"},{"issue":"12","key":"10.1016\/j.vhri.2026.101667_bib15","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1007\/s11136-015-1038-z","article-title":"Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases","volume":"24","author":"Sakthong","year":"2015","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.vhri.2026.101667_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12955-014-0203-3","article-title":"Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients","volume":"13","author":"Pattanaphesaj","year":"2015","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.vhri.2026.101667_bib17","series-title":"Guidelines for Health Technology Assessment in Thailand","first-page":"77","article-title":"Health utility","author":"Thavorncharoensap","year":"2021"},{"issue":"4","key":"10.1016\/j.vhri.2026.101667_bib18","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/bjd.16883","article-title":"Validity of the EQ-5D in patients with pemphigus vulgaris and pemphigus foliaceus","volume":"180","author":"Tam\u00e1si","year":"2019","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.vhri.2026.101667_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00403-024-03786-4","article-title":"Comparison of health-related quality of life in atopic dermatitis, hidradenitis suppurativa, pemphigus and psoriasis","volume":"317","author":"Bal\u00e1zs","year":"2025","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"10.1016\/j.vhri.2026.101667_bib20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/14737167.2018.1494574","article-title":"The EQ-5D-5L Valuation study in Thailand","volume":"18","author":"Pattanaphesaj","year":"2018","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"3","key":"10.1016\/j.vhri.2026.101667_bib21","first-page":"113","article-title":"The validity and reliability of the Dermatology Life Quality Index (DLQI) in Thais","volume":"20","author":"Kulthanan","year":"2004","journal-title":"Thai J Dermatol"},{"key":"10.1016\/j.vhri.2026.101667_bib22","series-title":"Statistics in Medicine","first-page":"189","article-title":"Regression and correlation","author":"Colton","year":"1974"},{"issue":"1","key":"10.1016\/j.vhri.2026.101667_bib23","first-page":"19","article-title":"The need to report effect size estimates revisited: an overview of some recommended measures of effect size","volume":"21","author":"Tomczak","year":"2014","journal-title":"Trends Sport Sci"},{"issue":"2","key":"10.1016\/j.vhri.2026.101667_bib24","first-page":"45","article-title":"The effect size in scientific publication","volume":"26","author":"S\u00e1nchez-Meca","year":"2023","journal-title":"Educ XX1"},{"issue":"1","key":"10.1016\/j.vhri.2026.101667_bib25","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1186\/s12889-024-18391-3","article-title":"EQ-5D-3L and EQ-5D-5L population norms for Thailand","volume":"24","author":"Kangwanrattanakul","year":"2024","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.vhri.2026.101667_bib26","first-page":"15","article-title":"Quality of life in patients with autoimmune bullous disorders: a cross-sectional study","volume":"26","author":"Ghareh Aghaji Zare","year":"2023","journal-title":"Iran J Dermatol"},{"issue":"2","key":"10.1016\/j.vhri.2026.101667_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaad.2008.09.014","article-title":"Quality-of-life assessment in patients with pemphigus using a minimum set of evaluation tools","volume":"60","author":"Paradisi","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.vhri.2026.101667_bib28","first-page":"110","article-title":"Correlation between quality of life assessed by Thai-version of Skindex-29 scores and disease severity among patients with pemphigus","volume":"36","author":"Uengpitakphan","year":"2020","journal-title":"Thai J Dermatol"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926000828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926000828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:15:40Z","timestamp":1789895740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109926000828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":28,"alternative-id":["S2212109926000828"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101667","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health Utility and Validity of the EQ-5D-5L in Thai Patients With Pemphigus and Bullous Pemphigoid","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101667"}}